8 niðurstöður
TECHNICAL FIELD
This invention relates to methods and compositions for treating cancer. More particularly, the invention provides cannabidiol derivatives and compositions thereof.
BACKGROUND
The hemp plant Cannabis sativa, commonly referred to as marijuana, has been used to alleviate symptoms of
FIELD
Described herein are microneedle drug delivery systems comprising: a pharmaceutical composition comprising pharmaceutically active agents (e.g., cannabinoids, such as cannabidiol or prodrugs of cannabidiol) and microneedle arrays suitable for local and systemic delivery to a mammal, including
RELATED APPLICATION
This application is a national stage filing under 35 U.S.C. .sctn. 371 of International Application No. PCT/GB2015/051876, filed Jun. 26, 2015, which was published under PCT Article 21(2) in English, the entire contents of which are hereby incorporated by reference.
The present
TECHNICAL FIELD OF THE INVENTION
The present invention pertains to a treatment for diseases associated with immune dysfunction, particularly HIV disease and neoplastic disorders.
BACKGROUND OF THE INVENTION
The retroviral Human Immunodeficiency Viruses 1 and 2 (HIV) are the most common causative
RELATED APPLICATIONS
This application is a national stage filing under 35 U.S.C. .sctn.371 of international application PCT/GB2009/050621, filed Jun. 4, 2009, which was published under PCT Article 21(2) in English.
The present invention relates to the use of a combination of cannabinoids in the
FIELD OF THE INVENTION
The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined
FIELD OF THE INVENTION
The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined
RELATED APPLICATION
This application is a national stage filing under 35 U.S.C. .sctn. 371 of international application PCT/GB2014/051889, filed Jun. 19, 2014, which was published under PCT Article 21(2) in English, the disclosure of which is incorporated by reference herein in its entirety.
The